NEW APPROACHES FOR ADJUVANT DEVELOPMENT IN PROPHYLACTIC VACCINES
Dr Else Marie Agger, Head of Research, SSI joined us at the World Vaccine Congress Lyon 2012 to lead a discussion into new approaches for adjuvant development in prophylactic vaccines.
Why not download the full presentation and discover more about new approaches for vaccine adjuvants development in prophylactic vaccines. Dr Agger's covered the following discussion points:
- Overview of adjuvant development
- Novel two component adjuvants for induction of cell-mediated immune responses
- Case studies with a focus on preclinical development, manufacturing process and human phase I trials